Treatment selection for patients with metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment selection for patients with metastatic renal cell carcinoma

Published:2009-04-28 Issue:S10 Volume:115 Page:2327-2333
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Atkins Michael B.¹²,Choueiri Toni K.²³,Cho Daniel¹²,Regan Meredith²⁴,Signoretti Sabina²⁵

Affiliation:

1. Division of Hematology/Oncology Beth Israel Deaconess Medical Center, Boston, Massachusetts

2. Kidney Cancer Program, Dana Farber Harvard Cancer Center, Boston, Massachusetts

3. Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts

4. Department of Biostatistics, Dana Farber Cancer Institute, Boston, Massachusetts

5. Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts

Funder

Genentech, Novartis Pharmaceuticals, Pfizer, Inc., and Wyeth Pharmaceuticals

DF/HCC Renal Cancer SPORE-NIH/NCI

Bayer and Novartis

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.24231

Reference39 articles.

1. Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

2. Sunitinib Efficacy Against Advanced Renal Cell Carcinoma

3. Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma

4. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and molecular basis of therapeutic approaches to breast cancer;Cellular Signalling;2023-01

2. Overexpression of FOXO4 induces apoptosis of clear-cell renal carcinoma cells through downregulation of Bim;Molecular Medicine Reports;2016-01-15

3. Adult Renal Cell Carcinoma;Surgical Pathology Clinics;2015-12

4. Biomarkers for Renal Cell Carcinoma;Kidney Cancer;2015

5. Carbonic Anhydrase IX is Not a Predictor of Outcomes in Non-Metastatic Clear Cell Renal Cell Carcinoma - A Digital Analysis of Tissue Microarray;International braz j urol;2013-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3